Cairney Maria, Crampin Lisa, Campbell Linsay, Cleland Joanne
University of Strathclyde, 50 George Street, Glasgow, G1 1QE, UK.
NHS Greater Glasgow and Clyde, Royal Hospital for Children, 1345 Govan Road, Govan, Glasgow, G51 4TF, UK.
Pilot Feasibility Stud. 2025 May 6;11(1):61. doi: 10.1186/s40814-025-01640-6.
Despite its growing popularity, there is limited evidence of the effectiveness of ultrasound visual biofeedback speech therapy for children with cleft palate ± cleft lip (CP ± L). This study reports on the findings of a pilot feasibility study of ultrasound visual biofeedback versus standard care. Results will be used to determine if a full-scale randomised controlled trial (RCT) is feasible.
We used a mixed-methods pilot RCT. Participants were children aged 5-16 with repaired CP ± L and at least one compensatory articulation. Participants were randomised, stratified for age, to receive six sessions of either articulation therapy (standard care) or ultrasound visual biofeedback (U-VBF) therapy. Outcome indicators for progression to full trial were measured as percentage targets achieved including the following: participants recruited and retained; outcome measure completion; and therapy protocol adherence. Due to the nature of treatment, the treating Speech and Language Therapists (SLTs) and families were not blinded; however, the assessing SLTs were blinded to treatment allocation until the end of the trial.
Eight participants were randomised to articulation therapy and eleven to ultrasound. All participants' data was included for analysis. All but one of the pre-determined criteria for moving to full trial were fully met and the remaining indicator was partially met. At least 75% of the following were achieved: outcome measure completion; therapy protocol adherence; participant retention in each arm of the study. The target number of participants, 20 per treatment arm, was not reached.
Most feasibility measures were successful. This study suggests that a full RCT comparing articulation therapy to U-VBF therapy would be possible if the current recruitment strategy is addressed.
ISRCTN, ISRCTN17441953. Registered 22 March 2021.
尽管超声视觉生物反馈言语治疗在腭裂±唇裂(CP±L)儿童中越来越受欢迎,但关于其有效性的证据有限。本研究报告了一项超声视觉生物反馈与标准护理的试点可行性研究结果。结果将用于确定全面随机对照试验(RCT)是否可行。
我们采用了混合方法的试点随机对照试验。参与者为年龄在5至16岁之间、已修复CP±L且至少有一种代偿性发音的儿童。参与者按年龄分层随机分组,接受六次发音治疗(标准护理)或超声视觉生物反馈(U-VBF)治疗中的一种。作为推进至全面试验的结果指标,以达到的百分比目标来衡量,包括以下方面:招募并留住的参与者;结果测量的完成情况;以及治疗方案的依从性。由于治疗的性质,治疗言语和语言治疗师(SLT)和家庭未设盲;然而,评估的言语和语言治疗师在试验结束前对治疗分配情况不知情。
8名参与者被随机分配到发音治疗组,11名被分配到超声治疗组。所有参与者的数据均纳入分析。除一项推进至全面试验的预定标准外,其他标准均完全满足,其余指标部分满足。以下各项至少达到了75%:结果测量的完成情况;治疗方案的依从性;研究各臂中的参与者留存率。未达到每个治疗组20名参与者的目标数量。
大多数可行性措施取得成功。本研究表明,如果解决当前的招募策略问题,进行一项比较发音治疗与U-VBF治疗的全面随机对照试验是可行的。
ISRCTN,ISRCTN17441953。2021年3月22日注册。